1. Search Result
Search Result
Results for "

2055491-00-2

" in MCE Product Catalog:
Cat. No. Product Name Target Research Areas
  • HY-P99536
    Tagraxofusp

    SL-401

    Interleukin Related Cancer
    Tagraxofusp (SL-401) is a potent IL-3 receptor inhibitor to inhibits plasmacytoid dendritic cells (pDCs) growth in multiple myeloma (MM) bone marrow (BM) microenvironment. Tagraxofusp has synergistic effect with Bortezomib (HY-10227) and Pomalidomide (HY-10984) to suppress multiple myeloma (MM).